vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Real Brokerage Inc (REAX). Click either name above to swap in a different company.

Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.2B vs $568.5M, roughly 2.2× Real Brokerage Inc). Alignment Healthcare, Inc. runs the higher net margin — 0.9% vs -0.1%, a 1.0% gap on every dollar of revenue. On growth, Real Brokerage Inc posted the faster year-over-year revenue change (52.6% vs -74.7%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Anywhere Real Estate Inc., formerly Realogy, was an American real estate services firm. It operated and franchised real estate brands that provided brokerage, relocation, title, insurance, and settlement services. Brands included Better Homes and Gardens Real Estate, Century 21 Real Estate, Coldwell Banker, Corcoran Group, ERA Real Estate and Sotheby's International Realty. In 2026, the company was acquired by Compass, Inc.

ALHC vs REAX — Head-to-Head

Bigger by revenue
ALHC
ALHC
2.2× larger
ALHC
$1.2B
$568.5M
REAX
Growing faster (revenue YoY)
REAX
REAX
+127.4% gap
REAX
52.6%
-74.7%
ALHC
Higher net margin
ALHC
ALHC
1.0% more per $
ALHC
0.9%
-0.1%
REAX

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
ALHC
ALHC
REAX
REAX
Revenue
$1.2B
$568.5M
Net Profit
$11.4M
$-447.0K
Gross Margin
7.9%
Operating Margin
-0.1%
Net Margin
0.9%
-0.1%
Revenue YoY
-74.7%
52.6%
Net Profit YoY
82.7%
EPS (diluted)
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
REAX
REAX
Q1 26
$1.2B
Q4 25
$1.0B
Q3 25
$993.7M
$568.5M
Q2 25
$1.0B
$540.7M
Q1 25
$926.9M
$354.0M
Q4 24
$701.2M
Q3 24
$692.4M
$372.5M
Q2 24
$681.3M
Net Profit
ALHC
ALHC
REAX
REAX
Q1 26
$11.4M
Q4 25
$-11.0M
Q3 25
$3.7M
$-447.0K
Q2 25
$15.7M
$1.5M
Q1 25
$-9.1M
$-5.0M
Q4 24
$-31.1M
Q3 24
$-26.4M
$-2.6M
Q2 24
$-24.0M
Gross Margin
ALHC
ALHC
REAX
REAX
Q1 26
Q4 25
Q3 25
7.9%
Q2 25
8.9%
Q1 25
9.6%
Q4 24
Q3 24
8.6%
Q2 24
Operating Margin
ALHC
ALHC
REAX
REAX
Q1 26
Q4 25
-1.0%
Q3 25
0.8%
-0.1%
Q2 25
2.2%
0.3%
Q1 25
-0.6%
-1.5%
Q4 24
-3.2%
Q3 24
-2.8%
-0.7%
Q2 24
-2.7%
Net Margin
ALHC
ALHC
REAX
REAX
Q1 26
0.9%
Q4 25
-1.1%
Q3 25
0.4%
-0.1%
Q2 25
1.5%
0.3%
Q1 25
-1.0%
-1.4%
Q4 24
-4.4%
Q3 24
-3.8%
-0.7%
Q2 24
-3.5%
EPS (diluted)
ALHC
ALHC
REAX
REAX
Q1 26
Q4 25
$-0.04
Q3 25
$0.02
$0.00
Q2 25
$0.07
$0.01
Q1 25
$-0.05
$-0.02
Q4 24
$-0.15
Q3 24
$-0.14
$-0.01
Q2 24
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
REAX
REAX
Cash + ST InvestmentsLiquidity on hand
$705.6M
$38.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$206.9M
$53.6M
Total Assets
$1.3B
$145.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
REAX
REAX
Q1 26
$705.6M
Q4 25
$604.2M
Q3 25
$644.1M
$38.7M
Q2 25
$503.8M
$49.7M
Q1 25
$479.5M
$24.7M
Q4 24
$470.6M
Q3 24
$381.0M
$22.6M
Q2 24
$363.7M
Total Debt
ALHC
ALHC
REAX
REAX
Q1 26
Q4 25
$323.2M
Q3 25
$322.7M
Q2 25
$322.3M
Q1 25
$321.9M
Q4 24
$321.4M
Q3 24
$212.0M
Q2 24
$211.7M
Stockholders' Equity
ALHC
ALHC
REAX
REAX
Q1 26
$206.9M
Q4 25
$179.3M
Q3 25
$161.9M
$53.6M
Q2 25
$141.0M
$49.2M
Q1 25
$108.1M
$32.8M
Q4 24
$99.9M
Q3 24
$114.5M
$29.8M
Q2 24
$123.7M
Total Assets
ALHC
ALHC
REAX
REAX
Q1 26
$1.3B
Q4 25
$1.1B
Q3 25
$1.1B
$145.2M
Q2 25
$1.0B
$149.4M
Q1 25
$895.6M
$100.5M
Q4 24
$782.1M
Q3 24
$692.3M
$102.5M
Q2 24
$716.3M
Debt / Equity
ALHC
ALHC
REAX
REAX
Q1 26
Q4 25
1.80×
Q3 25
1.99×
Q2 25
2.29×
Q1 25
2.98×
Q4 24
3.22×
Q3 24
1.85×
Q2 24
1.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
REAX
REAX
Operating Cash FlowLast quarter
$128.7M
$8.8M
Free Cash FlowOCF − Capex
$8.4M
FCF MarginFCF / Revenue
1.5%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
11.27×
TTM Free Cash FlowTrailing 4 quarters
$71.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
REAX
REAX
Q1 26
$128.7M
Q4 25
$-50.4M
Q3 25
$144.6M
$8.8M
Q2 25
$29.1M
$41.0M
Q1 25
$16.6M
$15.9M
Q4 24
$-8.7M
Q3 24
$26.2M
$7.2M
Q2 24
$23.5M
Free Cash Flow
ALHC
ALHC
REAX
REAX
Q1 26
Q4 25
$-55.4M
Q3 25
$139.1M
$8.4M
Q2 25
$21.1M
$40.8M
Q1 25
$8.4M
$15.7M
Q4 24
$-18.0M
Q3 24
$16.9M
$6.8M
Q2 24
$11.8M
FCF Margin
ALHC
ALHC
REAX
REAX
Q1 26
Q4 25
-5.5%
Q3 25
14.0%
1.5%
Q2 25
2.1%
7.5%
Q1 25
0.9%
4.4%
Q4 24
-2.6%
Q3 24
2.4%
1.8%
Q2 24
1.7%
Capex Intensity
ALHC
ALHC
REAX
REAX
Q1 26
Q4 25
0.5%
Q3 25
0.6%
0.1%
Q2 25
0.8%
0.0%
Q1 25
0.9%
0.1%
Q4 24
1.3%
Q3 24
1.3%
0.1%
Q2 24
1.7%
Cash Conversion
ALHC
ALHC
REAX
REAX
Q1 26
11.27×
Q4 25
Q3 25
38.77×
Q2 25
1.86×
27.13×
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons